Lymphoproliferative disorders in multiple primary cancers

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 383-386

  Demirci, Umut ^a   Ozdemir, Nuriye ^a   Benekli, Mustafa ^a   Babacan, Nalan Akgul ^a   Cetin, Bulent ^a   Baykara, Meltem ^a   Coskun, Ugur ^a   Zengin, Nurullah ^a   Buyukberber, Suleyman ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Diffuse large B cell lymphoma; Lymphoproliferative disorders; Multiple primary cancers

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864883422     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.383     Document Type: Article

References (25)

1. Armitage JO (2000) Myelodysplasia and acute leukemia after autologous bone marrow transplantation. J Clin Oncol, 18, 945-6.
2. Bassal M, Mertens AC, Taylor L, et al (2006). Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol, 24, 476-483.
3. Brennan P, Scelo G, Hemminki K, et al (2005). Second primary cancers among 109.000 cases of non-Hodgkin's lymphoma. Br J Cancer, 93, 159.
4. Chaturvedi AK, Engels EA, Gilbert ES, et al (2007). Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst, 99, 1634-43.
5. Cardous Ubbink MC, Heinen RC, Bakker PJ, et al (2007). Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer, 43, 351-62.
6. Demirci U, Bugdayci F, Cakir A, et al (2010). Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report. Med Oncol, 27, 481-3.
7. De Vathaire F, Hawkins M, Campbell S, et al (1999). Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer, 79, 1884-93.
8. Dong C, Hemminki K (2001). Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer, 85, 997-1005.
9. Dores GM, Metayer C, Curtis RE, et al (2002). Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol, 20, 3484-94.
10. Dores GM, Cote TR, Travis LB (2006). New malignancies following Hodgkin lymphoma, non-Hodgkin lymphoma and myeloma. In: Curtis R, Freedman D, Ron F et al., eds. New malignancies among cancer survivors: SEER cancer registries, 1973-2000 (NIH Publ. No: 05-5302). 397, National Institutes of Health, Bethesda MD.
11. Hisada M, Chen BE, Jaffe ES, Travis LB (2007). Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst, 99, 215-22.
12. Hodgson DC, Gilbert ES, Dores GM, et al (2007). Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol, 25, 1489-97.
13. Ganz PA (2001). Late effects of cancer and its treatment. Semin Oncol Nurs, 17, 241-8.
14. Jenkinson HC, Hawkins MM, Stiller CA, et al (2004). Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer, 91, 1905-10.
15. Krishnan B, Morgan GJ (2007). Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev, 16, 377-80.
16. Meadows AT, Friedman DL, Neglia JP, et al (2009). Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol, 27, 2356-62.
17. Neglia JP, Maedows AT, Robison LL, et al (1991). Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med, 325, 1330-6.
18. Neglia JP, Friedman DL, Yasui Y, et al (2001). Second malignant neoplasms in five-year survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst, 93, 618-29.
19. Ng AK, Travis LB (2008) Subsequent malignant neoplasms in cancer survivors. Cancer J, 14, 429-34.
20. Olsen JH, Garwicz S, Hertz H, et al (1993). Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ, 307, 1030-6.
21. Ries L, Eisner M, Kosary C, et al (2006). SEER cancer statistics review. 1975-2003. National Cancer Institute, Bethesda MD.
22. Swerdlow SH, Campo E, Harris NL, et al (2008). In: WHO Classification of Tumours of Haematopoietic and LymphoidTissues, 4th ed, 12-13, Lyon, IARC Pres.
23. Travis LB, Curtis RE, Glimelius B, et al (1993). Second cancers among long-term survivors of non-Hodgkin's disease. J Natl Cancer Inst, 85, 1932-7.
24. Travis LB, Curtis Re, Glimelius B, et al (1995). Bladder and kidney cancer following cyclophosphomide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst, 87, 524.
25. Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK (2006). The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer, 107, 108-15.